Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose

@article{TunstallPedoe2011CardiovascularRA,
  title={Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose},
  author={Hugh Tunstall-Pedoe},
  journal={Heart},
  year={2011},
  volume={97},
  pages={442 - 444}
}
Coronary heart disease and stroke contribute significantly to premature mortality and morbidity. Largely preventable, they demand prevention. Emphases range from responsibilities of governments to individuals, and the clinic nurses or doctors advising and treating them. The risk of cardiovascular disease varies. To be efficient and effective, medical interventions must focus on those at highest risk. The strongest marker of risk is existing cardiovascular disease (diabetes often included… Expand
Do novel biomarkers add to existing scores of total cardiovascular risk?
TLDR
The Net Reclassification Improvement index provides an indication of the ability of a novel marker to improve risk estimation by classifying individuals to a more correct category, and may be useful in correctly reclassifying individuals at intermediate risk as above or below a chosen intervention threshold. Expand
New directions in cardiovascular risk assessment: the role of secondary risk stratification markers
  • A. Wierzbicki
  • Medicine
  • International journal of clinical practice
  • 2012
TLDR
Large scale meta‐analyses ideally of pooled primary patient data will be required to determine the best additional markers to add to conventional risk prediction and in what groups to apply them. Expand
Almanac 2012: cardiovascular risk scores. The journals present selected research that has driven recent advances in clinical cardiology.
  • J. Pell
  • Medicine
  • Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology
  • 2013
TLDR
The scope of risk scores has recently widened beyond coronary heart disease to other conditions, such as heart failure and diabetes mellitus and there has been an increasing number of studies examining whether they can add value to existing risk scores. Expand
Almanac 2012: cardiovascular risk scores. The National Society Journals present selected research that has driven recent advances in clinical cardiology.
  • J. Pell
  • Medicine
  • Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
  • 2012
TLDR
Global risk scores use individual level information on non-modifiable risk factors and modifiablerisk factors to predict an individual's absolute risk of an adverse event over a specified period of time in the future. Expand
Almanac 2012: cardiovascular risk scores. The national society journals present selected research that has driven recent advances in clinical cardiology
  • J. Pell
  • Medicine, Geography
  • Heart
  • 2012
TLDR
Global risk scores can be helpful in informing patients, motivating them to change their lifestyle, and reinforcing the importance of continued compliance in assessing the effectiveness of an intervention at reducing an individual’s risk of future adverse events. Expand
Almanac 2012: Cardiovascular risk scores. The national society journals present selected research that has driven recent advances in clinical cardiology
TLDR
Global risk scores can be helpful in informing patients, motivating them to change their lifestyle, and reinforcing the importance of continued compliance in assessing the effectiveness of an intervention at reducing an individual’s risk of future adverse events. Expand
Almanac 2012: cardiovascular risk scores. The national society journals present selected research that has driven recent advances in clinical cardiology.
  • J. Pell
  • Geography, Medicine
  • Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
  • 2013
TLDR
Global risk scores can be helpful in informing patients, motivating them to change their lifestyle, and reinforcing the importance of continued compliance in assessing the effectiveness of an intervention at reducing an individual’s risk of future adverse events. Expand
New Risk Markers for Cardiovascular Prevention
TLDR
Investigation of subclinical vascular damage may improve total CV risk estimation in asymptomatic subjects who are close to a threshold that could affect management decisions and in whom the chances of re-classification in a different risk category are great. Expand
Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?
TLDR
In the current issue of the Journal, Nakajima et al. investigated the accuracy of three risk models derived from the J-ACCESS study to predict major events in a new cohort. Expand
Starting statins for primary prevention of cardiovascular disease
TLDR
Despite exceptional mortality rates half a century ago, anyone in Britain asking a doctor at that time how to avoid having a coronary heart attack, or wanting their cholesterol tested, risked being labelled a hypochondriac; evidence based medicine challenged prejudice. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 16 REFERENCES
Cardiovascular disease risk profiles.
TLDR
The equations demonstrated the potential importance of controlling multiple risk factors (blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, glucose intolerance, and left ventricular hypertrophy) as opposed to focusing on one single risk factor. Expand
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
TLDR
QRISK performed at least as well as the Framingham model for discrimination and was better calibrated to the UK population than either the Framingham model or ASSIGN. Expand
Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice
TLDR
For systematic CVD risk assessment all models could usefully be applied, but ASSIGN improved on the gradient of deprivation and accounted for recorded family history whereas the Framingham equations did not. Expand
By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease
TLDR
Cardiovascular risk estimated by the Framingham and related scores is misleading in guiding treatment decisions among people at different levels of social deprivation, exacerbating the social gradients in disease, which national policies seek to minimise. Expand
Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study
TLDR
It is concluded that the added value of fibrinogen to two currently used risk scores is low; hence population screening with fibr inogen for this purpose is unlikely to be clinically useful or cost‐effective. Expand
The Dundee coronary risk-disk for management of change in risk factors.
TLDR
The Dundee coronary risk-disk readout of Dundee rank, standardised on a scale of 1 to 100 by age and sex, is a simple, valid means of assessing and monitoring modifiable coronary risk. Expand
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
TLDR
The SCORE risk estimation system offers direct estimation of total fatal cardiovascular risk in a format suited to the constraints of clinical practice. Expand
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
TLDR
Conventional cardiovascular scores fail to target social gradients in disease, so ASSIGN shifts preventive treatment towards the socially deprived by including unattributed risk from deprivation. Expand
A strategy to reduce cardiovascular disease by more than 80%
TLDR
The Polypill strategy could largely prevent heart attacks and stroke if taken by everyone aged 55 and older and everyone with existing cardiovascular disease and with widespread use would have a greater impact on the prevention of disease in the Western world than any other single intervention. Expand
CORONARY HEART DISEASE IN MIDDLE-AGED FRENCHMEN Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project
TLDR
After adjustment to the risk-factor levels, major CHD incidence in the Paris study was comparable with that in the European population but lower than those in the U.S. Railroad population and pooling project population. Expand
...
1
2
...